High efficiency ex vivo cloning of antigen-specific human effector T cells.

While cloned T cells are valuable tools for the exploration of immune responses against viruses and tumours, current cloning methods do not allow inferences to be made about the function and phenotype of a clone's in vivo precursor, nor can precise cloning efficiencies be calculated. Additional...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michelle A Neller, Michael H-L Lai, Catherine M Lanagan, Linda E O'Connor, Antonia L Pritchard, Nathan R Martinez, Christopher W Schmidt
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d11adaf970244ecea3c97633192bcdc9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d11adaf970244ecea3c97633192bcdc9
record_format dspace
spelling oai:doaj.org-article:d11adaf970244ecea3c97633192bcdc92021-11-25T05:54:45ZHigh efficiency ex vivo cloning of antigen-specific human effector T cells.1932-620310.1371/journal.pone.0110741https://doaj.org/article/d11adaf970244ecea3c97633192bcdc92014-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0110741https://doaj.org/toc/1932-6203While cloned T cells are valuable tools for the exploration of immune responses against viruses and tumours, current cloning methods do not allow inferences to be made about the function and phenotype of a clone's in vivo precursor, nor can precise cloning efficiencies be calculated. Additionally, there is currently no general method for cloning antigen-specific effector T cells directly from peripheral blood mononuclear cells, without the need for prior expansion in vitro. Here we describe an efficient method for cloning effector T cells ex vivo. Functional T cells are detected using optimised interferon gamma capture following stimulation with viral or tumour cell-derived antigen. In combination with multiple phenotypic markers, single effector T cells are sorted using a flow cytometer directly into multi-well plates, and cloned using standard, non antigen-specific expansion methods. We provide examples of this novel technology to generate antigen-reactive clones from healthy donors using Epstein-Barr virus and cytomegalovirus as representative viral antigen sources, and from two melanoma patients using autologous melanoma cells. Cloning efficiency, clonality, and retention/loss of function are described. Ex vivo effector cell cloning provides a rapid and effective method of deriving antigen-specific T cells clones with traceable in vivo precursor function and phenotype.Michelle A NellerMichael H-L LaiCatherine M LanaganLinda E O'ConnorAntonia L PritchardNathan R MartinezChristopher W SchmidtPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 11, p e110741 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Michelle A Neller
Michael H-L Lai
Catherine M Lanagan
Linda E O'Connor
Antonia L Pritchard
Nathan R Martinez
Christopher W Schmidt
High efficiency ex vivo cloning of antigen-specific human effector T cells.
description While cloned T cells are valuable tools for the exploration of immune responses against viruses and tumours, current cloning methods do not allow inferences to be made about the function and phenotype of a clone's in vivo precursor, nor can precise cloning efficiencies be calculated. Additionally, there is currently no general method for cloning antigen-specific effector T cells directly from peripheral blood mononuclear cells, without the need for prior expansion in vitro. Here we describe an efficient method for cloning effector T cells ex vivo. Functional T cells are detected using optimised interferon gamma capture following stimulation with viral or tumour cell-derived antigen. In combination with multiple phenotypic markers, single effector T cells are sorted using a flow cytometer directly into multi-well plates, and cloned using standard, non antigen-specific expansion methods. We provide examples of this novel technology to generate antigen-reactive clones from healthy donors using Epstein-Barr virus and cytomegalovirus as representative viral antigen sources, and from two melanoma patients using autologous melanoma cells. Cloning efficiency, clonality, and retention/loss of function are described. Ex vivo effector cell cloning provides a rapid and effective method of deriving antigen-specific T cells clones with traceable in vivo precursor function and phenotype.
format article
author Michelle A Neller
Michael H-L Lai
Catherine M Lanagan
Linda E O'Connor
Antonia L Pritchard
Nathan R Martinez
Christopher W Schmidt
author_facet Michelle A Neller
Michael H-L Lai
Catherine M Lanagan
Linda E O'Connor
Antonia L Pritchard
Nathan R Martinez
Christopher W Schmidt
author_sort Michelle A Neller
title High efficiency ex vivo cloning of antigen-specific human effector T cells.
title_short High efficiency ex vivo cloning of antigen-specific human effector T cells.
title_full High efficiency ex vivo cloning of antigen-specific human effector T cells.
title_fullStr High efficiency ex vivo cloning of antigen-specific human effector T cells.
title_full_unstemmed High efficiency ex vivo cloning of antigen-specific human effector T cells.
title_sort high efficiency ex vivo cloning of antigen-specific human effector t cells.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/d11adaf970244ecea3c97633192bcdc9
work_keys_str_mv AT michelleaneller highefficiencyexvivocloningofantigenspecifichumaneffectortcells
AT michaelhllai highefficiencyexvivocloningofantigenspecifichumaneffectortcells
AT catherinemlanagan highefficiencyexvivocloningofantigenspecifichumaneffectortcells
AT lindaeoconnor highefficiencyexvivocloningofantigenspecifichumaneffectortcells
AT antonialpritchard highefficiencyexvivocloningofantigenspecifichumaneffectortcells
AT nathanrmartinez highefficiencyexvivocloningofantigenspecifichumaneffectortcells
AT christopherwschmidt highefficiencyexvivocloningofantigenspecifichumaneffectortcells
_version_ 1718414426915209216